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Abstract
Sterol regulatory element-binding protein (SREBP)-1c is the master regulator 
of lipogenic gene expression in liver.  The mRNA abundance of SREBP-1c is 
markedly induced when animals are refed after starvation, although the regulatory 
mechanism is so far unknown.  To investigate the mechanism of refeeding response of 
SREBP-1c gene expression in vivo, we generated a transgenic mouse model that carries 
2.2kb promoter region fused to the luciferase reporter gene.  These transgenic mice 
exhibited refeeding responses of the reporter in liver and adipose tissues with extents 
essentially identical to those of endogenous SREBP-1c mRNA.  The same results were 
obtained from experiments using adenovirus-mediated SREBP-1c-promoter-luciferase 
fusion gene transduction to liver.  These data demonstrate that the regulation of 
SREBP-1c gene expression is at the transcription level, and that the 2.2kb 5’-flanking 
region is sufficient for this regulation.  Moreover, when these transgenic or 
adenovirus-infected mice were placed on insulin-depleted state by streptozotocin 
treatment, the reporter expression was upregulated as strongly as in control mice, 
demonstrating that this regulation is not dominated by serum insulin level.  These mice 
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are the first models to provide the mechanistic insight into the transcriptional regulation 
of SREBP-1c gene in vivo.
Key words
lipogenesis, promoter analysis, insulin, transcription, liver, adipose tissue, transgenic 
mouse, adenovirus
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Introduction
The conversion of carbohydrate into fat is known as de novo lipogenesis, 
which is catalyzed by series of lipogenic enzymes such as acetyl-CoA carboxylase and 
fatty acid synthase [1].  The activities of these enzymes are nutritionally regulated, i.e.
downregulated when animals are starved and upregulated when they are refed.  This 
regulation of these lipogenic enzymes has two remarkable features.  First, their overall 
enzymatic activities largely depend on the amount of expressed protein that is primarily
controlled at the transcriptional level.  Second, their rates of transcription are 
coordinately regulated [2].  Therefore, it has been postulated that these genes share a 
regulatory sequence in their promoters that interacts with common trans-acting factors.  
In the liver, the most likely factor conducting this coordinate transcriptional regulation 
has been revealed to be sterol regulatory element-binding protein (SREBP) -1 [3, 4].
SREBPs are transcription factors that belong to the 
basic-helix-loop-helix-leucine zipper (bHLH-Zip) family and are considered to be 
profoundly involved in the transcriptional regulation of cholesterogenic and lipogenic 
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enzymes [5, 6].  The role of SREBP-1 in the regulation of lipogenesis in the liver has 
been well established by several lines of evidence, especially from transgenic and 
knockout mouse models [4, 7-9].  In these models, hepatic SREBP-1 protein levels 
dominate the mRNA expression levels for a battery of lipogenic genes.  Thus, 
SREBP-1 is now well established as the key transcription factor for the regulation of 
lipogenic gene expression and by extension triglyceride storage in liver [10, 11].
It has been well known that the mRNA and nuclear protein abundance of 
SREBP-1c, the main isoform of SREBP-1 in lipogenic organs such as liver and adipose 
tissue, is physiologically regulated by nutrient availability, i.e. it is downregulated when 
animals are starved and upregulated when they are refed, thereby adjusting lipogenic 
gene expression levels to the nutritional conditions [12].  Because the quantity of 
mRNA and nuclear protein of SREBP-1c goes up and down in parallel depending on 
dietary condition, the control at the mRNA expression level is considered primary at 
least in regard to refeeding response.  However, the mechanism of this regulation is yet 
to be clarified, including the point whether this regulation is at the transcription level or 
not.
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It has been reported that elevated concentrations of glucose and insulin mimic 
the refeeding state in vivo and upregulate SREBP-1 expression in cultured hepatocytes 
[13, 14].  However, these responses induced by high dosage of glucose and insulin are 
within two to three-fold changes at best, and far weaker than the refeeding response 
observed in the in vivo liver.  Therefore, to elucidate the precise mechanism of 
SREBP-1 regulation by nutrient availability, it is inevitable for one to study the in vivo
mouse model.
These situations prompted us to generate transgenic mice that carry 
SREBP-1c-promoter-driven reporter gene cassette to investigate the nutritional 
regulation of the promoter activities in vivo.  Moreover, based on the results from these
experiments, we further assessed the promoter activities using adenovirus-mediated 
gene delivery to the liver, which complemented the data from transgenic mice by 
excluding the potential possibility of positional effects in transgenic mouse model.
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Materials and Methods
Animals and treatment — Seven- to nine-week-old ICR and C57BL/6J male mice 
were purchased from CLEA (Tokyo, Japan).  All animals were housed in a 
temperature-controlled environment with a 12h-light / dark cycle and free access to 
standard laboratory diet (MF from Oriental Yeast, Tokyo, Japan, composed of 60% 
carbohydrate, 13% fat and 27% protein on a caloric basis) and water.  The protocol of 
dietary manipulation was as follows: for the fasting group, animals were starved 24h, 
and for the refeeding group, they were refed at 16h after a 24h starvation.  To make 
insulin-depleted states, streptozotocin (100 mg/kg body weight, Sigma) was 
administered by two intraperitoneal injections with 1-day interval following an 
overnight fasting period as described previously [15].  Streptozotocin was dissolved in 
50 mM sodium citrate buffer (pH 4.5) immediately before administration. Mice were 
considered diabetic when tail vain blood glucose levels exceeded 350 mg/dl, and 
euthanized within 8 days from the first injection.  All the experiments were repeated 
more than twice and reproducibility was confirmed.
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Production of Transgenic Mice — pBP1c2600Luc plasmid was constructed into pGL2 
basic vector (Promega) as previously described [16].  The SmaI-SalI fragment of this 
plasmid spanning -2.2k to +40 bp of the mouse SREBP-1c promoter fused to luciferase 
gene was microinjected into BDF1 eggs. Among the 55 offsprings, eight mice had the 
integrated transgene as determined by Southern blot hybridization of the tail DNA after 
digestion with BamHI or NheI.  The cDNA probe for luciferase gene was the 0.54kb 
XbaI-EcoRI fragment of pGL2-basic plasmid and the cDNA probe for mouse 
SREBP-1c promoter was the 1.1kb NheI fragment of SREBP-1c promoter cut out of the 
pBP1c2600Luc plasmid.  Among eight founder mice, two were crossbred to C57BL/6J 
background more than 5 times, and thus two lines of –2.2kb-SREBP-1c-promoter-Luc 
transgenic mice were established.  The other founder mice were not bred and could not 
be analyzed.
Generation of recombinant adenovirus — The SmaI-BglII fragment of 
pBP1c2600bp-Luc containing -2.2k to +40 bp of the mouse SREBP-1c promoter was 
subcloned into the pGL3 basic vector (Promega) at SmaI and BglII sites.  Then the
SREBP-1c promoter-luciferase gene cassette was cut out of the vector by NotI and SalI, 
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and after both ends were blunted with klenow DNA polymerase, it was subcloned into 
the pENTR4 vector (Invitrogen) at the EcoRI site (blunted).  Then, 
-2.2kb-SREBP-1c-promoter-Luc adenoviral plasmid was generated by homologous 
recombination between the subcloned pENTR4 plasmid and pAd promoterless vector 
using Clonase recombinase (Gateway system, Invitrogen).  Similarly, 
SV40-promoter-Luc control adenoviral plasmid was generated from pGL3 promoter 
vector (Promega). After the transfection of the plasmid into 293A cells, recombinant
adenoviruses were collected by CsCl gradient centrifugation according to the 
manufacturer’s instructions.  Following titer determination by limiting dilution, 
adenoviruses were injected intravenously into ICR male mice at the dose of 6.0 x 106 
P.F.U./body unless otherwise indicated.
RNA isolation and Northern blotting — Total RNA from liver and subctaneous fat 
pad was isolated with Trizol Reagent (Invitrogen), and 7.5g RNA sample equally 
pooled among each group was run on a 1% agarose gel containing formaldehyde and 
transferred to a nylon membrane.  cDNA probes were cloned as previously described
[4, 17, 18]. The probes were labeled with [-32P]dCTP using Megaprime DNA 
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Labelling System (Amersham Biosciences). The membranes were hybridized with the 
radiolabeled probe in Rapid-hyb Buffer (Amersham Biosciences) at 65C and washed in 
0.1x SSC buffer with 0.1% SDS at 65C.  Blots were exposed to imaging plate for 
BAS2000 BIO IMAGING ANALYZER (Fuji Photo Film, Tokyo, Japan).
Luciferase assays — Tissue samples (app. 50mg) were homogenized with a Polytron in 
300l of Reporter Lysis Buffer (Promega) and centrifuged at 15000 rpm for 15min, and 
luciferase activity in the supernatant was measured by standard kits (Promega) on a 
luminometer.  The luciferase activity was expressed as relative light units (RLU) / mg 
of used sample weight.
Adenoviral DNA isolation and quantification by real-time PCR — The pellets 
obtained in the process described above were digested in SNET buffer (1% SDS, 400 
mM NaCl, 5 mM EDTA and 20 mM Tris-HCl at pH 8.0) containing proteinase K (0.01 
mg/ml). After extraction with phenol / chloroform and RNase treatment, the pellets 
were dissolved in TE buffer and DNA concentrations were measured.  The amount of 
adenovirus DNA in liver was determined with Sybr-Green Dye (ABgene) -based
real-time PCR, the protocol of which was 50C for 2 min and 95C for 10 min, 
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followed by 60 cycles of 95C for 15 sec and 60C for 1 min using 50ng genomic DNA 
as a template on an ABI 7000 PCR instrument (Applied Biosystems).  The primers 
used for the quantification of luciferase gene were 
5’-GTCCGGTTATGTAAACAATCC-3’ and 5’-ATGAAGAAGTGTTCGTCTTCG-3’.
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Results and Discussion
Generation of transgenic mice carrying SREBP-1c promoter-luciferase fusion gene.
To examine the transcriptional regulation of SREBP-1c gene in vivo, we have 
generated transgenic mice carrying the luciferase reporter gene driven by the 2.2kb 
SREBP-1c 5’-flanking sequence that we have studied in vitro previously [16, 19].  The 
genomic structure of SREBP-1 gene has been previously clarified in detail [20], and the 
SREBP-1c promoter is located at 10kb downstream of the SREBP-1a promoter.  
Because refeeding manipulation selectively upregulates SREBP-1c rather than 
SREBP-1a [21], the responsible element was expected to be within the SREBP-1c 
5’-flanking region.  Since expression of reporter genes in transgenic animals might be 
affected by the location of genomic integration, we analyzed two independent founder 
lines, designated as line A and B.  From Southern blotting analyses of genomic DNA 
(Fig. 1B), line A and B mice were estimated to harbor 2 and 6 copies of transgene per 
allele, respectively.
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Transcriptional activation of the SREBP-1c promoter-driven transgene by 
refeeding.
For these lines of transgenic mice, the expression of reporter gene in liver and 
white adipose tissue was assessed by luciferase activity.  As shown in Fig. 2, the 
luciferase activities in the livers of both lines were markedly upregulated by refeeding 
manipulation, which paralleled the responses of endogenous SREBP-1c expression.  
This result means that the SREBP-1c expression is regulated at the transcription level in 
this situation, rather than through the variable stability of mRNA, which is reported to 
be involved in the regulation by polyunsaturated fatty acids [22].
The response of reporter gene in adipose tissue was apparently weaker than that 
of intrinsic gene.  This might result from weaker expression of transgene and relatively 
higher background level in adipose tissue compared to liver.
SREBP-1c induction by refeeding without insulin.
We have previously reported that the refeeding response of SREBP-1c does not 
require insulin [15].  To examine the role of insulin in this transcriptional upregulation 
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of the SREBP-1c by refeeding, we placed the transgenic mice on insulin-depleted state 
with streptozotocin treatment.  As shown in Fig. 3, increase in plasma insulin by 
refeeding was essentially abolished, but the SREBP-1c promoter activities as assessed 
by luciferase reporter expression were vigorously induced in the liver accompanied by
elevation in blood glucose levels.  This result indicates that insulin is not inevitable for 
the upregulation of SREBP-1c gene transcription by refeeding, consistent with our 
previous report [15].
Adenovirus-mediated transduction of SREBP-1c promoter-luciferase fusion gene 
into the mouse liver and assessment of refeeding response.
We further took another strategy for in vivo assay of SREBP-1c promoter 
activity using an adenovirus vector for introduction of the reporter gene into the liver.  
We generated an adenovirus harboring the 2.2kb promoter region of SREBP-1c fused to 
the luciferase reporter gene, and validated that intravenously administered adenoviruses 
are uniformly introduced into the mouse liver as shown in Fig. 4A.  Next we examined 
the refeeding responses of these adenovirus-infected mice expressing 
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SREBP-1c-promoter-luciferase fusion gene in the liver.  At the initial estimation, the 
absolute luciferase activities observed varied among individual mice in a wide range 
despite the same number of adenovirus particles for injection.  As shown in Fig. 4A, it 
was indicated that the variation among different portions of one liver was negligibly
small, thus most of the variation in measured luciferase activities was considered to 
originate from inter-mouse variation in viral transduction efficiency.  Two approaches
were taken to cancel this dispersion: 1. The amount of transducted adenoviral DNA was 
quantified by real-time PCR technique on each mouse and luciferase activity was 
adjusted based on this quantification (Fig.4B). 2. Liver samples on fasted and refed 
states were taken from the same mouse by biopsy under brief anesthesia and data of 
fasting and refeeding conditions from one mouse are analyzed consecutively (Fig.4C).  
Both approaches produced essentially the same results, and refeeding responses of 
twenty to thirty-fold increase in luciferase activities were consistently observed in a 
dose-independent way, which paralleled the increases in the endogenous SREBP-1c 
mRNA (Fig. 4E, F).  In contrast, when SV40-promoter-Luc adenovirus was used as a 
negative control instead of -2.2kb-SREBP-1c-promoter-Luc adenovirus, no refeeding 
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responses were observed (Fig. 4D).
These results are in complete accordance with those from transgenic mouse 
model described above.  Moreover, the adenoviral approach can avoid the potential 
involvement of positional effects that might influence transgenic mouse data.  It is 
intriguing that whether the promoter-reporter fusion gene is inserted in the genome (i.e. 
in the case of transgenic mouse) or not (i.e. in the case of adenovirus-mediated gene 
transfer) does not affect the regulation of the SREBP-1c promoter activity.
Evaluation of insulin involvement based on adenovirus-mediated reporter gene 
transfer technique.
The involvement of insulin was also evaluated using this adenovirus-mediated 
introduction of SREBP-1c-promoter-luciferase fusion gene into the liver.  As shown in 
Fig. 4G, streptozotocin-treated diabetic mice exhibited strong refeeding responses of 
luciferase reporter activities in a similar manner to the responses of intrinsic SREBP-1c 
mRNA, fully consistent with the data from transgenic mice.
Regarding the role of insulin in the upregulation of lipogenesis, many previous 
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reports indicate that insulin increases the expression of SREBP-1c and thereby 
upregulates lipogenesis [23-31].  However, our present methods clearly support that 
insulin signaling pathway does not directly control SREBP-1c expression.  This 
suggests that the insulin response in vitro might not be identical to the refeeding 
response in vivo, thus previous knowledge on in vitro promoter analyses of SREBP-1c 
regulation by insulin might not fully hold true of in vivo regulation.  For better 
understanding of the in vivo physiology, further studies of in vivo promoter analyses 
based on our reporter gene transfer technique utilizing adenovirus vector are currently 
ongoing.
 In summary, we generated two in vivo systems to estimate the SREBP-1c 
promoter activity.  It was demonstrated that the fasting-refeeding regulation of 
SREBP-1c expression in the liver is exerted at the transcription level, and that 2.2kb of 
the 5’-flanking sequence is sufficient for this regulation.  Our adenoviral strategy 
provides a feasible approach to identify the promoter regions responsible for refeeding 
response of SREBP-1c expression, which is currently under going.
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Figure legends
Fig. 1  Transgene construct and Southern blot.  A. Construct used to generate 
-2.2kb-SREBP-1c-promoter-Luc transgenic mice.  The mouse SREBP-1c promoter 
region spanning -2.2k to +40bp was fused to a luciferase reporter gene and SV40 late 
polyadenylation sequence.  B. Southern blotting of genomic DNA from transgenic 
mice.  Genomic DNA prepared from tail samples of wild-type (WT) controls and two 
lines (line A and B) of transgenic mice were analyzed by Southern blotting using two 
distinct probes.  For probe 1 (shown in upper panel), a cDNA probe for luciferase gene 
was used.  DNA samples were digested with BamHI.  For probe 2 (shown in lower 
panel), a cDNA probe for mouse SREBP-1c promoter region was used to determine the 
copy number of transgene.  DNA samples were digested with NheI.
Fig. 2  Refeeding response of transgenic mice.  A. Transgene expression as 
assessed by luciferase activities of liver and white adipose tissue (WAT) from two lines 
of transgenic mice.  Transgenic mice were either fasted for 24 h or refed for 16 h after 
- 28 -
a 24 h fast before euthanized.  Each group consists of 4 to 7 male mice.  Results are 
mean ± SE.  * and ** denote significance at P<0.05 and P<0.01, respectively.  B. 
Intrinsic gene expression as assessed by Northern blot analyses of wild type (WT) 
control and transgenic (Tg) mice.  Total RNA (7.5 g) from livers and white adipose 
tissues pooled equally among each group was subjected to Northern blotting analysis to 
determine SREBP-1 and 36B4 (used as a loading control) mRNA levels.  The 
quantification results were obtained with BAS2000 system and normalized to the signal 
generated from 36B4 mRNA, and the fold-changes between refed vs. fasted states are 
shown.  Wild type and transgenic mice were littermates.
Fig. 3  Refeeding response of streptozotocin-treated transgenic mice.  A. 
Transgene expression in streptozotocin-treated mouse liver as assessed by luciferase 
activity.  At two days after second administration of streptozotocin, transgenic mice 
were either fasted for 24 h or refed at 16 h after a 24 h starvation, and euthanized to 
obtain liver samples.  Luciferase activities of liver samples were determined as 
indicated in material and methods.  Results are mean ± SE of 4 to 6 male mice.  * and 
- 29 -
** denote significance at P<0.05 and P<0.01, respectively.  B. Northern blot analyses 
visualizing endogenous SREBP-1 mRNA expression pattern in streptozotocin-treated 
mouse liver.  Total RNA (7.5 g) from livers pooled equally among each group was 
subjected to Northern blotting to determine SREBP-1 and 36B4 (used as a loading 
control) mRNA levels.  The quantification results were obtained with BAS2000 
system and normalized to the signal generated from 36B4 mRNA, and the fold-changes 
between refed vs. fasted states are shown.  C. Blood insulin and glucose levels of 
streptozotocin-treated transgenic mice are shown.
Fig. 4  Adenovirus-mediated transduction of -2.2kb-SREBP-1c-promoter-Luc 
into liver and assessment of refeeding response.  A. Validation of homogenous 
transfer of reporter gene into various portions of liver.  Variation within a mouse liver 
was estimated by sampling 5 pieces of liver from distinct lobes after three days of 
-2.2kb-SREBP-1c-promoter-Luc adenovirus injection (6.0 x 106 P.F.U./body).  
Adenoviruses were intravenously injected into ICR male mouse.  B. Estimation of 
refeeding response of luciferase activity adjusted by real-time PCR.  Three days after 
- 30 -
the administration of -2.2kb-SREBP-1c-promoter-Luc adenovirus, luciferase activities
were measured and at the same time, the amount of transducted adenoviral DNA was 
quantified by real-time PCR technique on each mouse of fasting and refeeding group 
and luciferase activities per transducted adenoviral DNA were calculated based on this 
quantification.  50 ng genomic DNA was used as templates for real-time PCR.  
Results are mean ± SE of 4 to 5 mice.  ** denotes significance at P<0.01.  C. 
Pairwise estimation of refeeding response using biopsy method.  
-2.2kb-SREBP-1c-promoter-Luc adenovirus-administered mice were fasted for 24 h and 
then liver samples were taken by biopsy under inhalation anesthesia.  After refed for 
16 h, mice were euthanized to obtain refed liver samples.  Luciferase activities were 
determined and fold changes of luciferase activities were calculated by dividing data on 
a refed state by those of the same mouse on a fasted state.  Results are mean ± SE of 5 
mice.  ** denotes significance at P<0.01.  D. Negative control for data shown in C.  
SV40-promoter-Luc control adenovirus was used instead of 
-2.2kb-SREBP-1c-promoter-Luc adenovirus.  Results are mean ± SE of 4 mice.  E. 
Dose independence of refeeding response.  Indicated amounts of 
- 31 -
-2.2kb-SREBP-1c-promoter-Luc adenoviruses were intravenously injected into ICR 
male mice, and refeeding responses were assessed by pairwise method.  F, fasted; R, 
refed.  Results are mean ± SE of 3 mice.  F. Endogenous SREBP-1 expression is not 
affected by adenovirus administration. Total RNA (7.5 g) from livers pooled equally 
from each group (n=3) was subjected to Northern blotting analysis to determine 
SREBP-1 and 36B4 (used as a loading control) mRNA levels.  G. Refeeding response 
of luciferase reporter activity in adenovirus-infected and streptozotocin-treated mouse 
liver.  At two days after second administration of streptozotocin, 
-2.2kb-SREBP-1c-promoter-Luc adenovirus (6.0 x 106 P.F.U./body) was intravenously 
injected into ICR male mice.  Three days thereafter, mice were fasted for 24 h and then 
liver biopsies were performed under inhalation anesthesia.  After refed for 16 h, mice 
were euthanized to obtain liver sample.  Luciferase activities were measured and 
refeeding responses were determined pairwise.  Results are mean ± SE of 4 to 5 mice.  
** denotes significance at P<0.01.  H. Refeeding responses of endogenous SREBP-1 
mRNA expression in streptozotocin-treated mice.  Total RNA (7.5 g) from livers 
pooled equally among each group was subjected to Northern blotting analysis to 
- 32 -
determine SREBP-1 and 36B4 (used as a loading control) mRNA levels.  I. Blood 
insulin and glucose levels of the control and streptozotocin-administered mice are 
shown. 
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